Reporting of adverse drug reactions when used for clinical purposes is required for the safety of the pharmaceutical intervention. The absence of qualitative and quantitative data prevents a precise assessment of the risk / benefit profile of pharmaceutical products. Innovations are a new idea, a new device or a new process. Innovations mainy determine the application of best solutions that meet mainly new requirements, various needs or existing market needs. He is competent through more efficient products, processes, services, technologies or new ideas that are readily available to markets, governments and society. Innovations are something original and new, as important innovations that break into the market or society.
Awards 2021: Pharmaceutical Regulatory Affairs: Open Access
Awards 2021: Pharmaceutical Regulatory Affairs: Open Access
Young Research Forum: Pharmaceutical Regulatory Affairs: Open Access
Young Research Forum: Pharmaceutical Regulatory Affairs: Open Access
Review Article: Pharmaceutical Regulatory Affairs: Open Access
Review Article: Pharmaceutical Regulatory Affairs: Open Access
Short Communication: Pharmaceutical Regulatory Affairs: Open Access
Short Communication: Pharmaceutical Regulatory Affairs: Open Access
Review Article: Pharmaceutical Regulatory Affairs: Open Access
Review Article: Pharmaceutical Regulatory Affairs: Open Access
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Posters-Accepted Abstracts: Journal of Bioprocessing & Biotechniques
Posters-Accepted Abstracts: Journal of Bioprocessing & Biotechniques
Posters: Journal of Bioanalysis & Biomedicine
Posters: Journal of Bioanalysis & Biomedicine
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report